Abiopharma

Amneal Pharmaceuticals, Inc. - Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals

AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND

Neurocrine Biosciences to Host R&D Day on December 16

Praxis Precision Medicines Announces Alignment with FDA on Simplified and Accelerated Registrational Pathway for Elsunersen in Early Onset SCN2A Developmental and Epileptic Encephalopathy

Denali Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants

Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals

Neurocrine Biosciences to Host R&D Day on December 16

UTHR: Notification

Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama

New SEC Form for ResMed Inc.